Improving prevention of blood clots in cancer patients
Official title: An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
Funded at University of Michigan at Ann Arbor · NIH-10906164 · Data updated 2026-11-12
This study is looking for ways to help cancer patients avoid dangerous blood clots by using blood-thinning medications more effectively, so they can feel safer during their treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $171,168 |
| NIH project number | 5K01HL169920-02 |
| Project ID | NIH-10906164 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients who are at high risk for developing blood clots and are receiving systemic cancer therapy.
✕Less likely to help
Patients who are not undergoing cancer treatment or those who do not have a high risk for thrombosis may not benefit from this research.
What this research studies
This research focuses on enhancing the prevention of cancer-associated thrombosis (CAT) through better use of anticoagulant therapies in patients undergoing cancer treatment. The principal investigator, Dr. Jordan Schaefer, will receive training in qualitative research and implementation science to develop effective strategies for increasing the use of anticoagulants in community healthcare settings. The goal is to identify and implement interventions that can improve prophylaxis rates for patients at high risk of developing blood clots due to cancer. By addressing the barriers to effective treatment, this research aims to save lives and improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of blood clots in cancer patients, leading to improved survival rates and quality of life.
How similar studies have gone: Previous research has shown success in increasing prophylaxis rates in academic medical centers, indicating that similar approaches may be effective in community settings.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Schaefer, Jordan — University of Michigan at Ann Arbor
- Study coordinator: Schaefer, Jordan
Related research
Other NIH-funded projects on the same topics.
-
Role of blood flow mechanics and transfusion in sepsis-related tiny-cl vessel clots
A patient-focused look at how red blood cell flow and transfusions might influence tiny blood vessel clots and organ problems in sepsis.
-
Understanding how DVT forms and heals to prevent vein scarring
This NIH grant supports a physician-scientist to study why deep vein clots form and how vein walls get scarred, with the goal of improving long-term outcomes for patients who develop DVT.
-
Piezo1’s role in blood clotting across vessels
Researchers are exploring how a tiny sensor in blood vessels called Piezo1 influences clot formation, with the aim of reducing clotting risks without causing dangerous bleeding.
-
Oscillatory blood flow and vein valve health to prevent clots
Aimed at understanding how the natural rhythmic blood flow in leg veins protects against clots and whether restoring that flow can prevent dangerous vein clots in hospitalized patients.
-
Local anti-inflammatory therapy to help dissolve clots and prevent vein damage in DVT
Aims to test a local anti-inflammatory treatment to help resolve deep vein clots and reduce long-term vein problems in people with DVT.
-
Precision risk tools for blood clots and bleeding in critically ill children
A pediatric-focused project will use existing data from many hospitals to build and test a risk model that helps doctors decide which very sick kids might benefit from clot-prevention therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.